Category Archives: Medtronic Infuse

Featured Stories
Warning for Medtronic InterStim Neurostimulation Devices

Australian Health Agency Issues Warning for Battery Problem with Medtronic InterStim Neurostimulation Devices

Warning for Medtronic InterStim Neurostimulation DevicesTGA has issued a safety warning for InterStim and InterStim II neurostimulation devices, because of possible early depletion of the battery.

Read More

FDA Urged to Ban Powdered Caffeine

FDA Urged to Ban Powdered Caffeine

Pennsylvania Senator Robert Casey has written to the Food and Drug Administration (FDA) to urge the agency to ban powdered caffeine, a dietary supplement.

Read More

Metal-on-Metal Hip Replacement Device

Smith & Nephew’s Birmingham Metal-on-Metal Hip Replacement Device

Wright Medical Inc. took steps in to 2006 to convince the U.S. Food & Drug Administration (FDA) to reject pre-market approval of rival Smith & Nephew’s Birmingham metal-on-metal hip implant. Wright Medical, which makes two metal-on-metal hip replacement devices, the Conserve and the Lieneage device, filed a citizen petition ...

Read More

Birth Control Shot Depo-Provera may Increase HIV Risk

Birth Control Shot Depo-Provera may Increase HIV Risk, Study Suggests

A new study has linked the use of Depo-Provera (medroxyprogesterone acetate), an injectable type of birth control, to an increased risk of HIV infection.

Read More

Johnson & Johnson Facing More Metal-on-Metal Hip Implant Woes, as DePuy Pinnacle Complaints Rise

Having already spent around $3 billion on its DePuy Orthopaedics ASR hip implant recall, Johnson & Johnson is facing another potential debacle involving a metal-on-metal version of its Pinnacle Hip Replacement System. According to a report from Reuters, Johnson & Johnson and its DePuy unit already face some 1,600 metal-on-metal ...
British Recall of Smith & Nephew Renasys Wound Care System

British Recall of Smith & Nephew Renasys Wound Care System for Infection Risk

The MHRA announced the recall of Smith & Nephew Renasys wound care devices - risk of maceration, infection, loss of negative pressure, or unrecognized bleeding in wounds.

Read More

Three Injured, Long Island Railroad Train Hits Car on Tracks

Three Injured When Long Island Railroad Train Hits Car on Tracks

Three people, including a train engineer, were injured on Wednesday when a Long Island Rail Road train hit a livery cab on the tracks west of Wyandanch station, LIRR officials said. LIRR spokesman Salvatore Arena said the driver of the Lincoln Town Car was taken to Good Samaritan Hospital Medical Center ...

Read More

Canadian Study Finds Actos Raises Bladder Cancer Risk by 22 Percent

Yet another study is confirming the association between the diabetes drug, Actos, and bladder cancer. This latest research, published today in the Canadian Medical Association Journal, found that taking Actos raised the risk of bladder cancer among diabetics by about one-fifth.

Read More

Retailers Accused of Selling Fraudulent Herbal Supplements

Major Retailers Accused of Selling Fraudulent Herbal Supplements

The NYS attorney general’s office has accused four national retailers of selling fraudulent dietary supplements.

Read More

Medtronic Infuse Lawsuit Alleges Off-Label Use Cause Painful Complications

A man in Louisiana has filed suit against Medtronic Inc. over injuries allegedly cause by off-label use of its Infuse Bone Graft product. The plaintiff, who received Infuse during transforaminal spinal lumbar fusion surgery, claims that the bone growth protein caused unwanted bone growth along his spine, worsening the back ...

Read More

Medtronic Seeks Reconsideration of Infuse Ruling

medtronic_seeking_reconsideration

Device maker, Medtronic, just asked a federal judge to reconsider a ruling in a lawsuit involving its bone growth protein product, Infuse. Medtronic asked Judge G. Murray Snow, U.S. District Court for Arizona, to dismiss the lawsuit on the grounds … Continue reading

Posted in Defective Medical Devices, Defective Products, Medtronic Infuse |

Medtronic’s InFuse Sales Soft for Second Quarter Over Safety Issues

medtronic_sales_drop

Revenues for the bone graft product, InFuse, were down for the second quarter, due to ongoing safety issues. Medtronic’s InFuse, has long been steeped in controversy, including a Senate probe, a warning issued by a federal regulator, accusations that Medtronic … Continue reading

Posted in Defective Medical Devices, Medtronic Infuse |

Cincinnati Spine Surgeon Facing Fraud Charges Over InFuse

spine_surgeon_fraud

A Cincinnati spine surgeon has been charged with millions of dollars in fraudulent billing for unnecessary operations using Medtronic’s bone-growth product Infuse. Dr. Abubakar Atiq Durrani, who has a private practice with offices in Evendale and Florence, Kentucky called Center … Continue reading

Posted in Medtronic Infuse |

Industry Promises Increased Transparency, Medtronic InFuse Debacle Cited

drug_company_transparency

Some of the world’s largest drug makers have promised to release detailed information about their pharmaceutical products, such as Medtronic’s InFuse, to external researchers. While many are happy with the move, others point out that this might be a way … Continue reading

Posted in Defective Medical Devices, Medtonic Infuse, Medtronic Infuse |

Medtronic’s Motion to Dismiss InFuse Lawsuit Denied

infuse_lawsuit_goes_through

An Illinois state court judge just denied device maker, Medtronic Inc.’s, bid to dismiss a lawsuit brought over its InFuse bone graft product. The lawsuit included allegations that InFuse caused a patient to undergo additional surgery that led to permanent … Continue reading

Posted in Defective Medical Devices, Medtonic Infuse, Medtronic Infuse |

Pending Sunshine Act to Focus on Allegedly Fraudulent Financial Ties Between Physicians and Industry

sunshine_act_physicians

On August 1, the Physician Payment Sunshine Act provision of the Affordable Care Act will go into effect. The Act is meant to highlight allegedly bogus relationships between physicians and pharmaceutical firms and medical device manufacturers. As we’ve long stressed, … Continue reading

Posted in Defective Medical Devices, Medtonic Infuse, Medtronic Infuse |

Increased Transparency in Medicine Coming

medical_research_changes

When approved by the U.S Food and Drug Administration in 2002, Medtronic’s bone graft product, InFuse, was seen as a medical breakthrough. InFuse eliminated the need to remove patient bone from the hip in spinal fusions and could, instead, use … Continue reading

Posted in Defective Medical Devices, Medtonic Infuse, Medtronic Infuse |

Injured InFuse Users Working Toward Their Day in Court

medtronic_infuse_victims

Hundreds of people allegedly injured following procedures involving Medtronic’s InFuse are utilizing a different legal approach. The arguments planned include that the U.S. Food and Drug Administration (FDA) issued a warning in 2008 to physicians concerning “life-threatening complications” from unapproved … Continue reading

Posted in Defective Medical Devices, Medtonic Infuse, Medtronic Infuse |

Do Consumers Know the Risks of Medtronic InFuse? Are Consumers Aware of Safer Options?

medtronic_infuse_danger_alternatives

Medtronic’s bone graft product, InFuse, is a synthetic, or genetically engineered, recombinant human Bone Morphogenetic Protein (rhBMP-2) that was approved by the U.S. Food & Drug Administration (FDA) in 2002 for specific uses. Meant to stimulate spine growth in patients … Continue reading

Posted in Defective Medical Devices, Medtonic Infuse, Medtronic Infuse |

Medtronic Shareholders File Lawsuit Amid InFuse® Scandal

medtronic_shareholders_lawsuit

  Device maker, Medtronic, is the focus of another shareholder lawsuit over its InFuse® bone growth product. Shareholders filed the lawsuit against Medtronic and some of its shareholders accusing them of intentionally minimizing potential dangers associated with InFuse® so that … Continue reading

Posted in Defective Medical Devices, Medtonic Infuse, Medtronic Infuse |

© 2005-2018 Parker Waichman LLP ®. All Rights Reserved.